Altogether, we demonstrated that RanGAP1 downregulation can mediate BCR-ABL nuclear entrapment to activate P73-dependent apoptosis pathway which is a novel strategy for improving current IM treatment for CML. The gene discussed is RANGAP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.